Loading…
Lisata Therapeutics, Inc. is projected to rise to $3.75 by 2027, a +14% move from its current price of $3.30. LSTA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.19 | $3.30 | $3.41 | -0.03% |
| May 30 | $3.15 | $3.30 | $3.46 | -0.06% |
| May 31 | $3.11 | $3.30 | $3.49 | -0.09% |
| Jun 1 | $3.08 | $3.30 | $3.52 | -0.11% |
| Jun 2 | $3.06 | $3.30 | $3.55 | -0.14% |
| Jun 3 | $3.04 | $3.29 | $3.57 | -0.17% |
| Jun 4 | $3.02 | $3.29 | $3.60 | -0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.02 | $3.29 | $3.60 | -0.20% |
| Week 2 | $2.90 | $3.29 | $3.72 | -0.40% |
| Week 3 | $2.82 | $3.28 | $3.82 | -0.60% |
| Week 4 | $2.75 | $3.27 | $3.90 | -0.80% |
| Week 5 | $2.68 | $3.27 | $3.98 | -1.00% |
| Week 6 | $2.63 | $3.26 | $4.04 | -1.20% |
| Week 7 | $2.58 | $3.25 | $4.11 | -1.40% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.
Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens.
The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Lisata Therapeutics, Inc. trades under the symbol LSTA and is currently priced at $3.14 per share, with a market cap of $28.59M and a market rank of 4826.
The 2026 forecast shows an average price of $3.14, a low of $1.93, a high of $4.39, and a ROI of 0; sentiment NEUTRAL.
Looking further out, the forecast turns bullish as averages rise toward the late 2020s and 2030s, with 2028 averaging $4.13 and 2030 averaging $5.51, and by 2050 the average reaches $22.97 with a max of $46.65; cumulative ROIs grow to 31.5% by 2028, 75.4% by 2030, and 631.6% by 2050.
A major floor 34.5% below — a decisive break under it would weaken the trend.
The nearest floor, 14.2% below — buyers have tended to step in here.
The nearest ceiling, 21.5% above — a clean break opens room to run.
A major ceiling 52.7% above — clearing it would confirm fresh momentum.
Key LSTA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LSTA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.19 | Buy | $3.21 | Buy |
| MA 10 | $3.17 | Buy | $3.20 | Buy |
| MA 20 | $3.20 | Buy | $3.28 | Buy |
| MA 50 | $3.93 | Sell | $3.62 | Sell |
| MA 100 | $3.93 | Sell | $3.62 | Sell |
| MA 200 | $3.11 | Buy | $3.35 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.14 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 105.21 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 4.76 | Buy |
| Bollinger %B (20,2) | 0.85 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.95 | Sell |
| Awesome (5,34) | -0.23 | Sell |
| Ultimate (7,14,28) | 62.48 | Neutral |
| Momentum (10) | 0.04 | Buy |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 3.21 | Buy |
| ADX (14) | 30.26 | Sell |
| ATR (14) | 0.08 | Info |
The 30-day technical picture shows sentiment BULLISH with RSI14 of 40, SMA50 of $4.00, and SMA200 of $3.10.
The stock trades between support at $2.83 and resistance at $4.99, with a 30-day range from $2.50 to $3.94.
The annualized volatility is 70.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.93 | $3.30 | $4.56 | 0% | Neutral | |
| $2.91 | $3.75 | $5.15 | +14% | Neutral | |
| $3.28 | $4.37 | $6.25 | +32% | Bullish | |
| $4.06 | $5.56 | $8.24 | +69% | Bullish | |
| $4.14 | $5.82 | $8.86 | +76% | Bullish | |
| $4.17 | $6.00 | $9.36 | +82% | Bullish | |
| $4.13 | $6.08 | $9.69 | +84% | Bullish | |
| $4.04 | $6.06 | $9.85 | +84% | Bullish | |
| $4.85 | $7.42 | $12.29 | +125% | Bullish | |
| $5.76 | $8.99 | $15.14 | +172% | Bullish | |
| $6.14 | $10.45 | $18.88 | +217% | Bullish | |
| $12.22 | $24.30 | $48.57 | +636% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.93 | $3.30 | $3.90 | +0.00% |
| June 2026 | $2.83 | $3.34 | $4.05 | +1.19% |
| July 2026 | $2.70 | $3.21 | $3.96 | -3.73% |
| August 2026 | $2.71 | $3.26 | $4.06 | +1.32% |
| September 2026 | $2.82 | $3.41 | $4.29 | +4.64% |
| October 2026 | $2.79 | $3.40 | $4.32 | -0.34% |
| November 2026 | $2.75 | $3.37 | $4.32 | -0.76% |
| December 2026 | $2.87 | $3.53 | $4.56 | +4.82% |
Click any year to see its month-by-month LSTA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The LSTA price prediction for 2026 points to an average of $3.30 (low $1.93, high $4.56) — a potential gain of 0% on today's $3.30. A consolidation phase looks the most probable path here.
In 2027, LSTA is projected to trade between $2.91 and $5.15, averaging $3.75 — a potential gain of +14% from today's $3.30. That is up +14% on the projected 2026 average. Price action looks broadly range-bound.
Lisata Therapeutics, Inc.'s 2028 outlook centres on $4.37, within a $3.28 to $6.25 range. That is up +16% on the projected 2027 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, LSTA could reach as high as $8.24, with a base case around $5.56 and support toward $4.06 — roughly +69% from $3.30. Momentum favours further upside here.
Expect LSTA to range from $4.14 to $8.86 through 2030. The $5.82 average target implies a +76% move from current prices. That is up +5% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The LSTA price prediction for 2031 points to an average of $6.00 (low $4.17, high $9.36) — a potential gain of +82% on today's $3.30. Momentum favours further upside here.
In 2032, LSTA is projected to trade between $4.13 and $9.69, averaging $6.08 — a potential gain of +84% from today's $3.30. That is up +1% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Lisata Therapeutics, Inc.'s 2033 outlook centres on $6.06, within a $4.04 to $9.85 range. That is 0% versus the projected 2032 average. That marks a +84% change versus current levels. Momentum favours further upside here.
By 2034, LSTA could reach as high as $12.29, with a base case around $7.42 and support toward $4.85 — roughly +125% from $3.30. Buyers look set to stay in control over this stretch.
Expect LSTA to range from $5.76 to $15.14 through 2035. The $8.99 average target implies a +172% move from current prices. That is up +21% on the projected 2034 average. Momentum favours further upside here.
The LSTA price prediction for 2040 points to an average of $10.45 (low $6.14, high $18.88) — a potential gain of +217% on today's $3.30. Buyers look set to stay in control over this stretch.
In 2050, LSTA is projected to trade between $12.22 and $48.57, averaging $24.30 — a potential gain of +636% from today's $3.30. That is up +132% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in LSTA today (≈ 303.030303 LSTA) could be worth
$7,362.39
+$6,362.39 (+636%) by 2050 · US Dollar
Based on the average projected LSTA price of $24.3 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LSTAwould be worth at today's price.
$1,000 invested in LSTA on May 27, 2025 (≈ 389.105068 LSTA) would be worth
$1,284.05
+$284.05 (+28.4%) today · 1.28× · US Dollar
Based on a LSTA entry price of $2.57 vs. today's $3.3.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.18 | $1,037.74 | +3.8% |
| 1 month ago | $3.12 | $1,057.69 | +5.8% |
| 3 months ago | $4.41 | $748.3 | -25.2% |
| 6 months ago | $2.06 | $1,601.94 | +60.2% |
| 1 year ago | $2.57 | $1,284.05 | +28.4% |
| All time (5.0y) ago | $23.25 | $141.94 | -85.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LSTA forecast.
Our base-case forecast reaches $6.60 around 2034.
Implied market cap at $6.60: $60.1M
The multi-year forecast indicates a shift to bullish sentiment after 2027, with 2027 forecast neutral and subsequent years showing rising averages and upside potential through 2030 and beyond.
In 2030, the average price is forecast at $5.51 with an ROI of 75.4% and a bullish stance.
By 2040, the average price is forecast at $9.79 with an ROI of 211.9%, and by 2050 the average is forecast at $22.97 with an ROI of 631.6%, both borne under a bullish outlook.
These are estimates, not guarantees, and carry uncertainty and risk.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $5.51, a low of $3.88, a max of $8.47, with an ROI of 75.4% and a bullish sentiment.
The long-term forecast is bullish, with 2050 average $22.97, max $46.65 and ROI 631.6%, and 2040 average $9.79 with ROI 211.9%. The 2026 forecast is neutral with ROI 0, indicating mixed near-term prospects; these are estimates and not guarantees.
The 2040 forecast shows a max of $17.93 and an average of $9.79, suggesting it could reach or surpass $10 by the 2040s; by 2050 the max is $46.65.
Current price is $3.14 and market capitalization is $28.59M.
The 30-day range is $2.50 to $3.94, with a support at $2.83 and a resistance at $4.99.
Lisata Therapeutics, Inc. Community Discussion
0Share your Lisata Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.